Molecular biology of pancreatic cancer

被引:10
作者
Belda-Iniesta, Cristobal [1 ,2 ]
Ibanez de Caceres, Inmaculada [3 ]
Barriuso, Jorge [1 ]
de Castro Carpeno, Javier [1 ]
Gonzalez Baron, Manuel [1 ,2 ]
Feliu, Jaime [1 ]
机构
[1] Univ Autonoma Madrid, Univ Hosp La Paz, Div Med Oncol, CSIC,Translat Oncol Unit, ES-28046 Madrid, Spain
[2] MD Anderson Canc Ctr Espana, Madrid, Spain
[3] Univ Autonoma Madrid, CSIC, Biomed Res Inst Alberto Sols, Translat Oncol Unit, ES-28046 Madrid, Spain
关键词
pancreatic cancer; K-ras; cyclins; TGF beta; STAT3; EGFr;
D O I
10.1007/s12094-008-0247-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Pancreatic cancer is a leading cause of cancer death. This devastating disease has the horrible honour of close to equal incidence and mortality rates. Late diagnosis and a constitutive resistance to every chemotherapy approach are responsible for this scenario. However, molecular biology tools in cooperation with translational efforts have dissected several secrets that underlie pancreatic cancer. Progressive acquisition of malignant, invasive phenotypes from pre-malignant lesions, recent revelations on core signalling pathways and new targeted designed trials offer a better future for pancreatic cancer patients. This review will summarise recent advances in the molecular biology of pancreatic cancer.
引用
收藏
页码:530 / 537
页数:8
相关论文
共 64 条
[1]
Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma [J].
Aguirre, AJ ;
Bardeesy, N ;
Sinha, M ;
Lopez, L ;
Tuveson, DA ;
Horner, J ;
Redston, MS ;
DePinho, RA .
GENES & DEVELOPMENT, 2003, 17 (24) :3112-3126
[2]
Connective tissue growth factor-specific antibody attenuates tumor growth, metastasis, and angiogenesis in an orthotopic mouse model of pancreatic cancer [J].
Aikawa, Takuma ;
Gunn, Jason ;
Spong, Suzanne M. ;
Klaus, Stephen J. ;
Korc, Murray .
MOLECULAR CANCER THERAPEUTICS, 2006, 5 (05) :1108-1116
[3]
Overexpression of ErbB2 in the exocrine pancreas induces an inflammatory response but not increased proliferation [J].
Alguel, Hana ;
Wagner, Martin ;
Lesina, Marina ;
Schmid, Roland M. .
INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (07) :1410-1416
[4]
Both p16Ink4a and the p19Arf-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse [J].
Bardeesy, N ;
Aguirre, AJ ;
Chu, GC ;
Cheng, KH ;
Lopez, LV ;
Hezel, AF ;
Feng, B ;
Brennan, C ;
Weissleder, R ;
Mahmood, U ;
Hanahan, D ;
Redston, MS ;
Chin, L ;
DePinho, RA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (15) :5947-5952
[5]
Modes of resistance to anti-angiogenic therapy [J].
Bergers, Gabriele ;
Hanahan, Douglas .
NATURE REVIEWS CANCER, 2008, 8 (08) :592-603
[6]
Aberrant p16INK4A and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma [J].
Biankin, AV ;
Biankin, SA ;
Kench, JG ;
Morey, AL ;
Lee, CS ;
Head, DR ;
Eckstein, RP ;
Hugh, TB ;
Henshall, SM ;
Sutherland, RL .
GUT, 2002, 50 (06) :861-868
[7]
Characterization of the CXCR4 signaling in pancreatic cancer cells [J].
Billadeau D.D. ;
Chatterjee S. ;
Bramati P. ;
Sreekumar R. ;
Shah V. ;
Hedin K. ;
Urrutia R. .
Journal of Gastrointestinal Cancer, 2006, 37 (4) :110-119
[8]
Tumor hypoxia correlates with metastatic tumor growth of pancreatic cancer in an orthotopic murine model [J].
Büchler, P ;
Reber, HA ;
Lavey, RS ;
Tomlinson, J ;
Büchler, MW ;
Friess, H ;
Hines, OJ .
JOURNAL OF SURGICAL RESEARCH, 2004, 120 (02) :295-303
[9]
VEGF-RII influences the prognosis of pancreatic cancer [J].
Büchler, P ;
Reber, HA ;
Büchler, MW ;
Friess, H ;
Hines, OJ .
ANNALS OF SURGERY, 2002, 236 (06) :738-749
[10]
Inactivation of Akt by the epidermal growth factor receptor inhibitor erlotinib is mediated by HER-3 in pancreatic and colorectal tumor cell lines and contributes to erlotinib sensitivity [J].
Buck, Elizabeth ;
Eyzaguirre, Alexandra ;
Haley, John D. ;
Gibson, Neil W. ;
Cagnoni, Pablo ;
Iwata, Kenneth K. .
MOLECULAR CANCER THERAPEUTICS, 2006, 5 (08) :2051-2059